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The cause of Cystic fibrosis liver disease (CFLD), is unknown. It is well recognized that hepat-
ic exposure to hydrophobic bile salts is associated with the development of liver disease. For
this reason, we hypothesize that, CFTR dependent variations, in the hepatic handling of hy-
drophobic bile salts, are related to the development CFLD. To test our hypothesis we studied,
inCftr-/- and control mice, bile production, bile composition and liver pathology, in normal
feeding condition and during cholate exposure, either acute (intravenous) or chronic (three
weeks via the diet). InCftr-/- and control mice the basal bile production was comparable. Intra-
venous taurocholate increased bile production to the same extent inCftr-/- and control mice.
However, chronic cholate exposure increased the bile flow significantly less inCftr-/-mice
than in controls, together with significantly higher biliary bile salt concentration inCftr-/-mice.
Prolonged cholate exposure, however, did not induce CFLD like pathology inCftr-/-mice.
Chronic cholate exposure did induce a significant increase in liver mass in controls that was
absent inCftr-/-mice. Chronic cholate administration induces a cystic fibrosis-specific hepato-
biliary phenotype, including changes in bile composition. These changes could not be associ-
ated with CFLD like pathological changes in CFmouse livers. However, chronic cholate
administration induces liver growth in controls that is absent inCftr-/-mice. Our findings point
to an impaired adaptive homeotrophic liver response to prolonged hydrophobic bile salt expo-
sure in CF conditions.
Introduction
Cystic fibrosis (CF) is caused by mutations in the CFTR gene [1,2]. Cystic fibrosis liver disease
(CFLD) develops in 5–10% of cystic fibrosis patients [3]. It is a serious complication of CF
[4,5]. CFLD is characterized by cirrhosis and patients often present with splenomegaly, hypers-
plenism and complications of portal hypertension, including variceal bleeding and ascites
[6,7]. Although the synthesis and excretory functions of the liver are usually spared, liver
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transplantation can be indicated in some CFLD patients [8]. Despite major advances in basic
knowledge about cystic fibrosis, the pathogenesis of CFLD is still unknown.
In the liver, CFTR is expressed exclusively at the apical membrane of the cholangiocytes lin-
ing the bile ducts [9,10]. In cholangiocytes, CFTR facilitates the water secretion and the pH of
bile [11,12]. Consequently, loss of CFTR function may increase the concentration of the poten-
tially cytotoxic bile salts in bile, leading to damage and occlusion of small bile ducts and, ulti-
mately, obstructive biliary cirrhosis [13–15].
CF mice may show minor gallbladder and liver abnormalities that, spontaneously, do not
lead to loss of liver function or CFLD like pathology [16–19]. Compared to humans, mice pro-
duce bile with relatively hydrophilic bile salts [20]. Hydrophilic bile salts are considered less cy-
totoxic than hydrophobic ones, which have been associated with the development of liver
disease [21,22]. The hydrophilic profile of murine bile could prevent or mitigate liver disease in
CF mice.
We speculate that, Cftr dependent variations, in the hepatic handling of hydrophobic bile
salts, might be related to the development of CFLD. To test this hypothesis in mice, we sought
to change the composition of murine bile to one containing more hydrophobic bile salts.
Therefore, we challenged CF mice, acutely and chronically, with cholic acid (CA), a relatively
hydrophobic bile salt with strong detergent activity, and monitored effects on bile production,
bile composition, hepatic gene expression, serum alanine transaminase (ALT) levels, liver
weight and liver histology [22].
Materials and Methods
Animals
We used C57Bl/6;129 Cftr-/-tm1CAM mice and Cftr +/+tm1CAM littermate controls. In one addi-
tional experiment, we use homozygous F508del Cftrmice (Cftrtm1EUR) mice and littermate
controls. All mice were bred and accommodated at the Animal Experimental Center of the
Erasmus Medical Center in Rotterdam, The Netherlands [16]. Mice were housed in a light-con-
trolled (lights on 6 AM to 6 PM) and temperature-controlled (21°C) facility, and had free ac-
cess to tap water and a semi-synthetic diet (SRM-A; Hope Farms BVWoerden, The
Netherlands) from the time of weaning. All experiments were performed with mice of 10–20
weeks of age. Group size varied per experiment, based on breeding success. We used a mini-
mum number of five mice per experimental group. Experimental protocols were approved by
the Ethical Committee for Animal Experiments of Erasmus MC. All surgery was performed
under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.
Experimental procedures
To test our hypothesis we used a murine gall bladder cannulation model [23,24]. Bile was col-
lected after surgical ligation of the common bile duct and cannulation of the gall bladder using
polyethylene tubing under intraperitoneal anesthesia with hypnorm (fentanyl/fluanisone 1 μl/g
BW) and diazepam (10 μg/g BW). The animals were placed in a temperature and humidity
controlled incubator. Bile secretions were collected in 15 or 30 minute fractions. Bile flow rate
was assessed gravimetrically, assuming a density of 1g/ml. [23,25].
We first applied acute bile salt infusion, as previously described [25]. After gall bladder
cannulation, we infused taurine-conjugated cholate (TCA) (43 mM dissolved in phosphate-
buffered saline, pH 7.4) via the jugular vein using an infusion pump. The bile salt dosage
was increased every 30 minutes in a stepwise manner (dosage steps 0, 150, 300, 450 and
600 nmol.min-1). Bile was collected in 15 minutes fractions.
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Different groups of Cftr-/- and control mice were either fed the control diet, composed
of standard chow or the bile salt diet, composed of standard chow enriched with cholate
(CA 0.5% wt/wt), for three weeks. An additional group of Cftr-/- and control mice were fed the
CA enriched diet for three months. After gallbladder cannulation as described above, bile pro-
duction was determined by bile collection for 30 minutes. The bile was collected for analysis.
Mice were then sacrificed by obtaining a large blood sample via cardiac puncture, followed by
cervical dislocation. The liver was excised and weighed, after which samples were either im-
mersed in neutral buffered formalin or stored in liquid nitrogen.
Analytical techniques
Biliary bile salt concentrations were determined by enzymatic fluorometric assay [26]. Lipids
were extracted from the bile [27]. The phospholipid concentrations were determined using a
spectrophotometric assay [28]. Biliary bile salt composition was determined by capillary gas
chromatography [29]. The hydrophobicity of bile salts in bile was calculated according to the
Heuman index, based on the fractional contribution of the major bile salt species [22]. ALT
was determined in plasma samples.
RNA was isolated from whole liver for quantitative real time polymerase chain reactions
(qRT-PCR) performed on a 7900HT Fast Real-Time PCR system (Applied Biosystems).
For histological analysis of the liver samples, hematoxylin/eosin staining was applied on par-
affin embedded sections. To quantify mitotic active cells we used Ki-67 immunostaining using a
rabbit anti Ki-67p monoclonal antibody (Novocastra Laboratories Ltd., Newcastle upon Tyne,
UK) [30]. An experienced hepato-pathologist (A.S.H.G.) assessed the liver samples in a blinded
fashion. Histology of the liver parenchyma and portal tracts were evaluated separately for in-
flammation, fibrosis, and Ki-67 mitotic activity. The score was performed in a semi-quantitative
approach on a scale from 0 to 3 (0: absent, 1: sporadic, 2: regular, 3: frequent) [31].
Statistical analysis
The statistical analysis was performed using SPSS version 18.0 for Windows (SPSS Inc., Chi-
cago, IL). All numerical results are reported as means ± SEM. The ordinal histology results are
reported as medians and range. Differences between study groups were evaluated using the
Mann-Whitney U test. The level of significance was set at a P value of less than 0.05.
Results
Bile production and bile salt secretion after interruption of the
enterohepatic circulation
Bile production, assessed over 30 minutes immediately after interruption of the enterohepatic
circulation, did not differ significantly between Cftr-/- mice and controls (mean of 2 15 min
points in first 30 minutes: 6.3±0.7 vs. 5.8±0.5 μl.min-1.100 g-1, respectively; Fig. 1A). Bile salt
concentrations and bile salt secretion rates were also similar between Cftr-/- mice and controls
under these untreated conditions (Fig. 1B and C).
Bile production and bile salt secretion during acute IV taurocholic acid
(TCA) administration
Administration of TCA (IV) dose-dependently increased bile production (Fig. 1A). The dose-
response relationship was similar for Cftr-/- mice and controls, indicating that bile production
was not impaired in CF mice. Also, a similar, concomitant dose-dependent increase in bile salt
concentrations and secretion rates was observed during TCA infusion, in Cftr-/- mice and
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controls (Fig. 1B and C). The bile salt secretion rate was linearly correlated with the bile flow
(Fig. 1D), with similar slopes in Cftr-/- and control mice, indicating similar magnitudes of bile
salt dependent bile flow. These observations strongly suggested that the bile flow in mice, both
under basal conditions and after acute IV TCA administration, is predominantly generated via
Cftr independent mechanisms.
Bile production and bile salt composition during chronic cholic acid (CA)
feeding
Feeding a CA containing diet for three weeks increased bile flow in Cftr-/- mice and controls
(Fig. 2A). However, the increase was significantly more pronounced in controls than in Cftr-/-
mice. The CA diet increased the biliary bile salt concentration in Cftr-/- mice but not in controls
(Fig. 2B). Chronic CA feeding increased the bile salt secretion rate in Cftr-/- mice and controls.
However, the bile salt secretion rate, during CA diet was not significantly different between
Cftr-/- mice and controls (Fig. 2C).
Fig 1. Biliary parameters during intravenous taurocholic acid (TCA) administration. Biliary bile flow (A), bile salt concentration (B), bile salt secretion
rate (C) and relationship between bile salt secretion rate and bile flow (D) in Cftr knockout mice (Cftr—/) and control littermates (Cftr+/+) during intravenous
infusion with TCA in stepwise increasing dosage of. The gray symbols in (D) represent baseline values before the start of TCA infusion. Data are presented
as means ± SEM of N = 5–7 mice per group. There was no significant difference betweenCftr-/- andCftr+/+ mice, at any of the individual time points, for bile
flow, bile salt concentration and bile salt secretion rate (regression lines:.Cftr-/-: y = 0.0044x + 7.9 vs. Cftr+/+: y = 0.0037x + 6.0).
doi:10.1371/journal.pone.0117599.g001
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Fig 2. Biliary parameters and bile composition of Cftr knockout mice (Cftr-/-) and controls, fed a control diet or a cholic acid (CA) containing diet for
3 weeks. Biliary bile flow (A), bile salt concentration (B), bile salt secretion rate (C), phospholipid concentration (D), phospholipid-to-bile salt ratio (E), serum ALT
levels (F), percent contribution to total biliary bile salts of cholate, deoxycholate and others (chenodeoxycholate, ursodeoxcholate, α-muricholate and β-
muricholate) (G), and, Heuman index of biliary bile salts representing the hydrophobicity (H), in Cftr knockout mice (Cftr-/-) and control littermates (Cftr+/+) after a
control or 0.5%-CA (wt/wt) chow diet for three weeks. Data are presented asmeans ± SEM or percentage (panel G) of N = 5–7 mice per group. *P-value<0.05.
doi:10.1371/journal.pone.0117599.g002
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To assess cytotoxicity, we measured the biliary phospholipid concentration and calculated
the phospholipid-to-bile salt ratio. During regular chow feeding (control diet), biliary phos-
pholipid concentrations were similar in Cftr-/- mice and controls (Fig. 2D), as were the phos-
pholipid to bile salt ratios (Fig. 2E). CA feeding seemed to increase phospholipid
concentrations, both in Cftr-/- and controls, but the differences between the diets did not reach
statistical significance (Fig. 2D). Also, the phospholipid concentration did not significantly dif-
fer between Cftr-/- and control mice on either diet. CA administration increased the phospho-
lipid to bile salt ratio only in control mice (Fig. 2E). On control diet, serum ALT levels were
similar in Cftr-/- and control mice (Fig. 2F). CA feeding slightly, but significantly, increased
serum ALT in control mice suggestive for minor hepatocyte injury. Also ALT levels also in-
creased in Cftr-/- mice upon the CA diet, but this was statistically not significant.
As anticipated, the biliary bile salt compositions in Cftr-/- and control mice were relatively
hydrophilic (i.e. negative Heuman indices), upon feeding the control diet (Fig. 2H). Even at
these control conditions, however, the hydrophobicity index was significantly higher in Cftr-/-
mice compared with controls (-0.33 vs. -0.26; respectively, P<0.01). The higher hydrophobicity
index could be attributed mainly to a higher fractional CA content in Cftr-/- mice (Fig. 2G).
The CA diet markedly increased the fractional contribution of CA to the total biliary bile salt
pool in both groups. In control mice, the CA contribution increased to ~90% whereas it was
even close to 100% in Cftr-/- mice. In the control mice, the remaining 10% consisted predomi-
nantly of the secondary bile salt deoxycholic acid. Since DCA is a more hydrophobic bile salt
than CA, the hydrophobicity index of the bile, after prolonged CA exposure, was higher in con-
trols than in Cftr-/- mice (0.06 vs. 0.00, respectively, P<0.01, Fig. 2H).
Hydrophobic bile salts are regarded as strong ligands for the nuclear receptor Fxr, which is,
among other functions, also involved in bile acid synthesis regulation. The observed significant
difference in DCA proportion upon CA treatment could correspond with differences in bile syn-
thesis rates between the genotypes. To address this possibility, we determined the mRNA expres-
sion of hepatic Cyp7a1, encoding the rate-limiting enzyme in bile salt synthesis from cholesterol.
During normal diet, the hepatic expression of Cyp7a1 was similar in Cftr-/- and control mice.
After prolonged CA exposure, however, the Cyp7a1 expression was completely suppressed in
control mice, but unaffected in Cftr-/- mice (Fig. 3A and B).
Cftr dependent effects of chronic CA exposure on liver weight
In accordance with earlier reports, Cftr-/- mice tended to a lower body weight as littermate con-
trols (Fig. 4A) [32]. CA feeding did not markedly affect body weight, but nevertheless, the dif-
ference between the two genotypes now was significant. On control diet, Cftr-/- and control
mice had similar absolute and relative liver weights (Fig. 4C and 4E). Chronic CA administra-
tion increased the absolute and relative liver weight in controls (+52%, p<0.001), but did not
affect either in Cftr-/- mice (Fig. 4C and 4E). We also observed the absence of CA-induced liver
growth response in mice expressing mutant Cftr (homozygous F508del Cftrmice; Cftrtm1EUR),
in contrast to their wild type littermates (Fig. 4B, 4D and 4F) [33]. The combined observations
indicate that chronic CA exposure induces liver growth, in different mouse strains, but does re-
quire functional Cftr expression.
Cftr dependent effects of chronic CA exposure on liver histology
On control diet, parenchymal cell proliferation was enhanced in Cftr-/- mice, relative to con-
trols (Fig. 5C), but no signs of parenchymal inflammation were evident. Chronic CA adminis-
tration increased parenchymal mitotic activity in controls to a level similar to that found in
Cftr-/- mice on either regular chow or after chronic CA exposure. Concomitantly, three week
The Biliary Phenotype of CF Mice Models
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CA feeding significantly increased the parenchymal inflammation score in controls (Fig. 5D).
Prolonged CA exposure (three months) further increased parenchymal mitotic activity and in-
flammation, particularly observed in controls. CA feeding did not generate pathological
changes in the portal tract areas of Cftr-/- or control mice (Fig. 5A and C). Fig. 6 shows
Fig 3. Hepatic Cyp7a1mRNA expression Cftr knockout mice (Cftr-/-) and controls, fed a control diet or a cholic acid (CA) containing diet for 3
weeks.Hepatic Cyp7a1 mRNA expression after a control (A) or 0.5%-CA (wt/wt) chow diet (B) for three weeks. Cyp7a1 mRNA levels were normalized to a
housekeeping gene (β-actin) inCftr knockout mice (Cftr-/-) and control littermates (Cftr+/+). Data are presented as means ± SEM of N = 5–7 mice per group.
*P-value<0.05.
doi:10.1371/journal.pone.0117599.g003
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representative images of liver histology after control and three weeks CA diet (panel A-D: HE
staining and panel E-H: Ki67 staining).
Discussion
In Cftr-/- mice, both acute and chronic hydrophobic bile salt administration markedly increased
biliary bile salt production and flow rates. However, Cftr-/- mice showed a reduced capacity to
adapt to chronic hydrophobic bile salt exposure, compared with control mice. Although biliary
bile salt production was similar in Cftr-/- and control mice, the increase in bile flow was signifi-
cantly less pronounced in the former. The reduced capacity, of the Cftr-/- mice, to increase bile
flow, during prolonged hydrophobic bile salt administration, resulted in significantly higher
bile salt concentrations in bile. Interestingly, acute intravenous bile salt administration did not
induce similar differences between Cftr-/- and control mice, indicating that only adaptations to
prolonged hydrophobic bile salt exposure are perturbed in CF.
Prolonged CA exposure did not result in CFLD like, histopathology in Cftr-/- mice, despite
their higher biliary bile salt concentration and lower bile salt to phospholipids ratio. These results
make it unlikely that hydrophobic bile salt cytotoxicity underlies the pathogenesis of CFLD. Dur-
ing normal feeding conditions, the hydrophobicity index of bile of Cftr-/- mice was slightly higher
than in control mice, due to an increased proportion of cholate. In contrast, however, the hydro-
phobicity index of bile was lower than in controls after prolonged CA exposure. The lower hy-
drophobicity in Cftr-/- mice, after prolonged CA exposure, was due to a higher contribution of
the hydrophobic secondary bile salt DCA in the control mice. DCA is exclusively formed from
CA by the intestinal bacterial microflora [34–36]. From these findings we suggest that Cftr de-
pendent alterations in the intestinal, bacterial biotransformation of bile salts are responsible for
the different biliary bile salt composition and hydrophobicity in CF mice conditions.
Fig 4. Body and liver weights in Cftr knockout,ΔF508 Cftr and control mice, fed a control diet or a
cholic acid (CA) containing diet for 3 weeks. Body weight (A, B), absolute liver weight (C,D) and relative
liver weight reported as a percentage of the body weight (E, F) inCftr knockout mice (Cftr-/-, panels A. C and E)
orΔF508Cftrmice (Cftrtm1EUR, panels B, D and F) and their respective control littermates (Cftr+/+), after a
control or 0.5%-CA (wt/wt) chow diet for three weeks. Data are presented asmeans ± SEM of N = 5–7 mice per
group. *P-value<0.05.
doi:10.1371/journal.pone.0117599.g004
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CF mouse models, in general, do not display histopathological signs of liver disease [37]. As
an exception, however, Durie et al. reported the development of spontaneous liver disease
upon ageing in the C57BL/6J Cftr-/-tm1Unc CF mice [17]. The Cftr-/-tm1Unc mice used by Durie
et al. have a different genetic background than the mice used in our present study. The differ-
ences between the mouse strains are compatible with the concept genetic modifiers affect the
hepatobiliary phenotype of CF. Considering the potential effects of intestinal microflora on
bile salt composition, environmental factors may additionally play a role [36].
Chronic CA exposure significantly increased liver mass in control mice. Interestingly, CA
induced liver growth was absent in CF mice. It was described previously that hydrophobic bile
salts can induce liver growth in mice. Huang et al. reported that CA feeding (0.2%) for five
days increased the relative liver weight by approximately 30% in wild type mice [38]. Song
et al. reported an 8% increase in relative liver weight in C57BL/6 mice fed a CA enriched diet
for one week [39]. These scientists also reported that DCA 0.3% for one week induce a 32%
Fig 5. Liver histology in Cftr knockout mice (Cftr-/-) and controls, fed a control diet or a cholic acid (CA) containing diet for 3 weeks or for 3 months.
Histological evaluation of liver parenchymal inflammation (A), parenchymal Ki67 activity (B), portal inflammation (C), and portal Ki67 activity (D), in Cftr
knockout mice (Cftr-/-) and control littermates (Cftr+/+) after a control diet, a 0.5%-CA (wt/wt) chow diet for three weeks, or a 0.5%-CA (wt/wt) chow diet for
three months. Histology was scored in a blinded and semi-quantitative fashion using an ordinal scale (0: absent; 1: sporadic; 2: regular; 3: frequent). All
results are presented individually per mouse; the horizontal black line represents the median of N = 5–7 mice per group. *P-value<0.05.
doi:10.1371/journal.pone.0117599.g005
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increase in relative liver weight suggesting that the effect of the more hydrophobic bile salt
DCA on liver growth was even more pronounced than that of CA.
It has been established that bile salt induced homeotrophic liver growth is regulated via the
nuclear receptor Fxr [40], either in the liver or in the intestine [41]. Our finding that liver growth
was absent in CA-fed Cftr-/- and CftrΔF508/ΔF508 mice suggested that FXR signaling is perturbed
in CF mice. This suggestion was supported by differences in Cyp7a1mRNA expression between
Cftr-/- and control mice after prolonged CA exposure. Hepatic Cftr is exclusively expressed in
cholangiocytes, what makes Cftr-Fxr interference at the level of the liver less likely. The intesti-
nal Fxr stimulated liver proliferation is probably mediated via the induction of the expression of
Fgf15 in the intestine [42]. Uriarte et al.recently reported that liver growth elicited by CA feeding
was significantly diminished in Fgf15-/- mice [43]. Since Fgf15 expression is regulated by intesti-
nal Fxr, these findings are compatible with a role for the intestinal Fxr-Fgf15 axis in liver growth
induction after hydrophobic bile salt exposure. In accordance with this concept, Debray et al.
showed that Fgf15 expression in Cftr-/- mice was low at the level of the ileum, suggesting altered
Fxr bile salt signaling at the level of the intestine in CF conditions [44].
Reactive oxygen species (ROS)-dependent signaling could also play a role in stimulation of
hepatocyte proliferation and liver regeneration [45]. Sokol et al. demonstrated that, in human
hepatocytes, mitochondria can generate ROS when exposed to hydrophobic bile salts [46].
However, we consider it less likely that this mechanism is involved for the liver growth and he-
patocyte proliferation found in our model. As stated above Cftr is only expressed in the cholan-
giocytes and not in hepatocytes. In addition, we determined hepatic heme-oxygenase 1 (HO-1)
expressions in our models, as a marker of hepatic oxidative stress. We observed no differences
between HO-1 expression between Cftr-/- and control mice before or after three week CA expo-
sure (data not shown). These considerations and findings indicate that, at least at the hepatic
level, chronic CA exposure, and liver growth are unlikely to be related to ROS-dependent sig-
naling or oxidative stress.
Fig 6. Liver histology of Cftr knockout mice (Cftr-/-) and controls, fed a control diet or a cholic acid (CA) containing diet for 3 weeks. Liver histology
(magnification 40x) of Cftr knockout mice (Cftr-/-) and control littermates (Cftr+/+) after a control or 0.5%-CA containing diet for three weeks. Liver slices with
HE staining (panels: A-D), or Ki67 staining on HE staining background (panels: E-H). The white arrows, pointing at Ki67 positive cells indicate active cell
proliferation in parenchymal and portal areas.
doi:10.1371/journal.pone.0117599.g006
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In summary, we show that, in mice, Cftr plays a role in the hepatic adaptive response to pro-
longed hydrophobic bile salt exposure. The CF condition is characterized by a reduction in bile
salt-induced hepatocyte proliferation, increase in biliary bile salt concentrations and difference
in secondary bile salt composition. These changes suggest that the CF condition may be more
prone to liver disease due to an impaired liver regeneration and homeotrophic liver growth re-
sponse upon exposure to hepatotoxic substances.
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